Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis
暂无分享,去创建一个
K. Tracey | Haichao Wang | Jianhua Li | X. Qiang | Weiqiang Chen | Ping Wang | Cassie Shu Zhu | Shujin Chen | C. Zhu
[1] K. Tracey,et al. Identification of procathepsin L (pCTS-L)–neutralizing monoclonal antibodies to treat potentially lethal sepsis , 2023, Science advances.
[2] David L. Williams,et al. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction , 2023, Science advances.
[3] K. Raza,et al. Proliposome-Based Nanostrategies: Challenges and Development as Drug Delivery Systems , 2022, AAPS PharmSciTech.
[4] Abdelwahab Omri,et al. Lipid-Based Drug Delivery Systems for Diseases Managements , 2022, Biomedicines.
[5] David L. Williams,et al. Lactate induces vascular permeability via disruption of VE-cadherin in endothelial cells during sepsis , 2022, Science advances.
[6] Neha Dhiman,et al. A drift on liposomes to proliposomes: recent advances and promising approaches , 2022, Journal of liposome research.
[7] K. Tracey,et al. Human Dermcidin Protects Mice Against Hepatic Ischemia-Reperfusion–Induced Local and Remote Inflammatory Injury , 2022, Frontiers in Immunology.
[8] David S. Fischer,et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics , 2021, Nature Medicine.
[9] D. Heffernan,et al. Emerging therapeutic targets for sepsis , 2021, Expert opinion on therapeutic targets.
[10] Yutian Li,et al. Tissue-Resident Macrophages in the Control of Infection and Resolution of Inflammation. , 2020, Shock.
[11] K. Tracey,et al. Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis , 2020, Science Translational Medicine.
[12] T. Buchman,et al. Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018* , 2020, Critical care medicine.
[13] Niranjan Kissoon,et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study , 2020, The Lancet.
[14] C. Deutschman,et al. Buprenorphine Markedly Elevates a Panel of Surrogate Markers in a Murine Model of Sepsis , 2019, Shock.
[15] K. Tracey,et al. Enhanced Macrophage Pannexin 1 Expression and Hemichannel Activation Exacerbates Lethal Experimental Sepsis , 2019, Scientific Reports.
[16] Minoru Yoshida. Recent advances in target identification of bioactive natural products , 2019, Bioscience, biotechnology, and biochemistry.
[17] K. Tracey,et al. Connexin 43 Hemichannel as a Novel Mediator of Sterile and Infectious Inflammatory Diseases , 2018, Scientific Reports.
[18] M. A. Lasunción,et al. Lanosterol Modulates TLR4-Mediated Innate Immune Responses in Macrophages. , 2017, Cell reports.
[19] Huan Yang,et al. Cathepsin L Promotes Vascular Intimal Hyperplasia after Arterial Injury , 2017, Molecular medicine.
[20] Y. Li,et al. Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans , 2017, International Urology and Nephrology.
[21] Mingzi M. Zhang,et al. Using natural products for drug discovery: the impact of the genomics era , 2017, Expert opinion on drug discovery.
[22] A. Cilla,et al. Impact of Lipid Components and Emulsifiers on Plant Sterols Bioaccessibility from Milk-Based Fruit Beverages. , 2016, Journal of agricultural and food chemistry.
[23] Susan Hua,et al. Advances and Challenges of Liposome Assisted Drug Delivery , 2015, Front. Pharmacol..
[24] Ming-Wei Lin,et al. Euphol from Euphorbia tirucalli Negatively Modulates TGF-β Responsiveness via TGF-β Receptor Segregation inside Membrane Rafts , 2015, PloS one.
[25] D. Vodnar,et al. Antioxidant, Antimicrobial Effects and Phenolic Profile of Lycium barbarum L. Flowers , 2015, Molecules.
[26] Ruben Abagyan,et al. Lanosterol reverses protein aggregation in cataracts , 2015, Nature.
[27] V. Nekkanti,et al. Proliposomes for oral delivery: progress and challenges. , 2015, Current pharmaceutical biotechnology.
[28] Haichao Wang,et al. PKM2 Regulates the Warburg Effect and Promotes HMGB1 Release in Sepsis , 2014, Nature Communications.
[29] Haichao Wang,et al. Carbenoxolone Blocks Endotoxin-Induced Protein Kinase R (PKR) Activation and High Mobility Group Box 1 (HMGB1) Release , 2013, Molecular Medicine.
[30] Soodabeh Davaran,et al. Liposome: classification, preparation, and applications , 2013, Nanoscale Research Letters.
[31] G. F. Passos,et al. The role of PKC/ERK1/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on TPA-induced skin inflammation in mice. , 2013, European journal of pharmacology.
[32] J. Calixto,et al. Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: The involvement of cannabinoid system , 2012, Neuropharmacology.
[33] C. Peters,et al. Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment , 2012, Inflammation Research.
[34] J. Calixto,et al. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms. , 2012, Biochemical pharmacology.
[35] H. Mansour,et al. Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery , 2012, Lung.
[36] J. Calixto,et al. Preventive and Therapeutic Euphol Treatment Attenuates Experimental Colitis in Mice , 2011, PloS one.
[37] K. Tracey,et al. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. , 2011, Biochemical pharmacology.
[38] J. Tschopp,et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.
[39] C. Peters,et al. Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice. , 2010, Gastroenterology.
[40] Huan Yang,et al. A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1 , 2007, PloS one.
[41] Fang-Yu Chen,et al. The condensing effect of cholesterol in lipid bilayers. , 2007, Biophysical journal.
[42] Christoph Peters,et al. Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice , 2007, Circulation.
[43] Javed Siddiqui,et al. Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality1 , 2006, The Journal of Immunology.
[44] K. Tracey,et al. Role of HMGB1 in apoptosis-mediated sepsis lethality , 2006, The Journal of Experimental Medicine.
[45] T. Starc,et al. Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis. , 2006, Gastroenterology.
[46] S. Krueger,et al. Bilayer thickness and thermal response of dimyristoylphosphatidylcholine unilamellar vesicles containing cholesterol, ergosterol and lanosterol: a small-angle neutron scattering study. , 2005, Biochimica et biophysica acta.
[47] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Winter,et al. Differential Properties of the Sterols Cholesterol, Ergosterol, β-Sitosterol, trans-7-Dehydrocholesterol, Stigmasterol and Lanosterol on DPPC Bilayer Order , 2003 .
[49] A. Harken,et al. TLR4 mediates LPS-induced HO-1 expression in mouse liver: Role of TNF-α and IL-1β , 2003 .
[50] M. Bloom,et al. From lanosterol to cholesterol: structural evolution and differential effects on lipid bilayers. , 2002, Biophysical journal.
[51] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[52] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[53] K. Tracey,et al. Spermine Inhibits Proinflammatory Cytokine Synthesis in Human Mononuclear Cells: A Counterregulatory Mechanism that Restrains the Immune Response , 1997, The Journal of experimental medicine.
[54] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[55] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.